已收盘 07-24 16:00:00 美东时间
-0.500
-2.08%
The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism around its depression treatment.
03-17 01:35
Pacifica Silver ( ($TSE:PSIL) ) has provided an update. Pacifica Silver has exp...
03-16 21:44
Compass Pathways' stock surges after late-stage depression trial success.
02-17 22:12
Quantum Biopharma's subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial.
2025-08-06 02:25
Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.
2025-05-25 04:11